Back to Search Start Over

Epoprostenol Use for Pulmonary Arterial Hypertension in the Palliative Care Setting.

Authors :
Wozencraft, Colin P.
Coyne, Patrick J.
Grinnan, Daniel C.
Morel, Thomas D.
Muzevich, Katie M.
Smith, Thomas J.
Source :
Journal of Palliative Medicine. May2012, Vol. 15 Issue 5, p619-622. 4p. 2 Charts.
Publication Year :
2012

Abstract

Prostacyclin analogues such as epoprostenol (Flolan®) are commonly used in the treatment of pulmonary arterial hypertension (PAH). However, their complex administration and significant cost may limit the access that patients with PAH have to palliative and hospice care. We herein report our experience using epoprostenol in a dedicated palliative care unit and present our inpatient protocol for the drug's administration. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10966218
Volume :
15
Issue :
5
Database :
Academic Search Index
Journal :
Journal of Palliative Medicine
Publication Type :
Academic Journal
Accession number :
75164109
Full Text :
https://doi.org/10.1089/jpm.2011.0182